Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies (Volume 161) (Advances in Cancer Research, Volume 161)
Original price was: $172.97.$101.75Current price is: $101.75.
Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies (Volume 161) (Advances in Cancer Research, Volume 161) | 9780443296284, Fisher, Paul B.
Author: Fisher, Paul B.
Edition: 1
ISBN: 9780443296284
Release Date: 12-08-2024
Package Dimensions: 9.0 x 6.0 x 1.0 inches
Languages: English
Binding: Hardcover
Number Of Pages: 498
Details: Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies, Volume 161 in the Advances in Cancer Research series, covers timely topics such as The Prostate Cancer Tissue N-glycome as a Source of Biomarkers, a Progression from Normal to Metastatic Disease, Multiplexed Targeted Proteomics for Prostate Cancer Biomarker Verification, MRI for the Detection of Clinically Significant Prostate Cancer: Update and Future Directions, Genetic and epigenetic factors for prostate cancer progression, Epigenetic regulation of androgen dependent and independent prostate cancer, Molecular Landscape of Prostate Cancer Bone Metastasis, Future of radioligand Therapy in PC, and more.
Additional chapters of note include Advancements in Computer Vision and Pathology: Unraveling the Potential of Artificial Intelligence for Precision Diagnosis and Beyond and Extracellular Vesicles in Prostate Cancer. Provides the latest information on cancer research Offers outstanding and original reviews on a range of cancer research topics Serves as an indispensable reference for researchers and students alike
User Reviews
Be the first to review “Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies (Volume 161) (Advances in Cancer Research, Volume 161)”
Vendor Information
- Store Name: Adobooks Marketplace
- Vendor: Adobooks Marketplace
- No ratings found yet!
Product Enquiry
Original price was: $172.97.$101.75Current price is: $101.75.


There are no reviews yet.